Jump to content
  • Sign Up
0
Scott Adams

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for ... - News-Medical.net

Rate this topic

Recommended Posts

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for ...

News-Medical.net

"We are delighted to have been awarded this grant from the NIH in recognition of the potential of our novel approach to the treatment of celiac disease," said Barbara S. Fox, Ph.D., Avaxia's founder and CEO. "This NIH support provides the funding we ...

Avaxia Biologics gets Phase I SBIR grant Pharmaceutical Business Review

all 4 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×